SCHEMBL17952128

SCHEMBL17952128

Cc1cnc2[nH]cc(-c3ccncc3)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 15/20 0.62
SLC2A1 P11166 1/20 0.59
PIK3CA P42336 2/20 0.58
KIT P10721 1/20 0.55
NEK1 Q96PY6 1/20 0.54
AXL P30530 1/20 0.53
CDK8 P49336 1/20 0.53
TNIK Q9UKE5 1/20 0.53
PLK4 O00444 1/20 0.50
AURKA O14965 1/20 0.50
JAK2 O60674 1/20 0.50
ROCK2 O75116 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
PRKCG P05129 1/20 0.50
INSR P06213 1/20 0.50
CDK1 P06493 1/20 0.50
FES P07332 1/20 0.50
IGF1R P08069 1/20 0.50
ROS1 P08922 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25785930 0.86 AXL (0.71) NTRK1NEK1AXLCDK8TNIK
SCHEMBL25839063 0.84 DYRK1A (0.63) NTRK1PIK3CAKITNEK1AXL
SCHEMBL25781685 0.82 NTRK1 (0.47) NTRK1SLC2A1PIK3CAKITAXL
SCHEMBL19068217 0.82 NTRK1 (0.70) NTRK1SLC2A1PIK3CAKITNEK1
SCHEMBL28614283 0.81 JAK2 (0.75) NTRK1SLC2A1PIK3CAKITNEK1
SCHEMBL17952449 0.81 NTRK1 (0.77) NTRK1SLC2A1PIK3CADYRK1A
SCHEMBL25839064 0.80 DYRK1A (0.56) NTRK1KITAXLCDK8TNIK
SCHEMBL26174763 0.80 KIT (0.49) NTRK1PIK3CAKITAXLCDK8
SCHEMBL3765160 0.79 CDK8 (0.85) NTRK1PIK3CANEK1AXLCDK8
SCHEMBL18576770 0.77 NTRK1 (1.00) NTRK1SLC2A1PIK3CAKITNEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131122-A1 FUSED RING-SUBSTITUTED SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 劲方医药科技(上海)有限公司 2023-07-13 WO disclosed
WO-2016118951-A2 HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER CONFLUENCE LIFE SCIENCES, INC. (US) 2016-07-28 WO disclosed